We previously reported a mutation in the cholesterol biosynthesis gene, hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7 rudolph ), that results in striking embryonic forebrain dysgenesis. Here we describe abnormal patterns of neuroprogenitor proliferation in the mutant forebrain, namely, a decrease in mitotic cells within the ventricular zone (VZ) and an increase through the remainder of the cortex by E11.5. Further evidence suggests mutant cells undergo abnormal interkinetic nuclear migration (IKNM). Furthermore, intermediate progenitors are increased at the expense of apical progenitors by E12.5, and post-mitotic neurons are expanded by E14.5. In vitro primary neuron culture further supports our model of accelerated cortical differentiation in the mutant. Combined administration of a statin and dietary cholesterol in utero achieved partial reversal of multiple developmental abnormalities in the Hsd17b7 rudolph embryo, including the forebrain. These results suggest that abnormally increased levels of specific cholesterol precursors in the Hsd17b7 rudolph embryo cause cortical dysgenesis by altering patterns of neurogenesis.
Introduction
Cholesterol homeostasis is critical for human health and is implicated in a number of disorders from cardiovascular disease in adults to severe developmental abnormalities in the embryo (Porter and Herman, 2011) . The developing embryo is especially susceptible to disruptions in cholesterol homeostasis, because the placental and blood-brain barriers can limit the transport of cholesterol between physiologic compartments. Consistent with a high requirement for in situ synthesis of cholesterol in the brain (Jurevics et al., 1997; Orth and Bellosta, 2012; Tint et al., 2006) , a common feature of genetic disorders of cholesterol biosynthesis are central nervous system (CNS) abnormalities. Because the brain is especially sensitive to perturbations in cholesterol metabolism, it is important to understand the mechanism(s) by which genetic or acquired (e.g., drug inhibition) deficiencies in enzymes of cholesterol biosynthesis affect cholesterol production and utilization during forebrain development.
Hsd17b7 (hydroxysteroid 17-beta dehydrogenase 7) encodes a 3-ketosteroid reductase that converts 4-methylzymosterone to 4α-methylzymosterol and zymosterone to zymosterol during postsqualene cholesterol biosynthesis (Marijanovic et al., 2003) . Null mutations in mouse Hsd17b7 lead to early embryonic death, precluding studies on the role of Hsd17b7 in brain development (Jokela et al., 2010; Shehu et al., 2008) . The Rudolph mutation is a hypomorphic allele of Hsd17b7 (Hsd17b7 rud ) which, when carried in the homozygous state, allows survival to mid-organogenesis with widespread CNS anomalies (Stottmann et al., 2011) . The CNS phenotype of the Hsd17b rud mutation is unique among known mutants in the cholesterol biosynthetic enzymatic pathway and provides a novel tool for studying the relationship between cholesterol metabolism and mammalian neural development. Consistent with reduced activity of Hsd17b7, sterol analysis of the Hsdb17b7 rud mutant revealed increased levels of cholesterol intermedi- 
